425 participants
Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-07-28
- Start Date:
- 2017-07-01
- Completion:
- 2018-12-12
Conditions
- HCV
Interventions
- DRUG
No Results Yet